Report Detail
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Insights, Forecast to 2025
- RnM3115944 |
- 28 July, 2020 |
- Global |
- 152 Pages |
- QYResearch |
- Other
Isothermal Nucleic Acid Amplification Technology (INAAT) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Isothermal Nucleic Acid Amplification Technology (INAAT) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
by Technology
Loop-mediated Isothermal Amplification
Nucleic Acid Sequence-based Amplification
Rolling Circle Amplification
Single Primer Isothermal Amplification
Helicase-dependent Isothermal DNA Amplification
Recombinase Polymerase Amplification
Strand Displacement Amplification
by Product Type
Assay
Kits
Reagents
Market segment by Application, split into
Infectious Disease Diagnosis
Blood Screening
Cancer Diagnosis
Cancer Research and Laboratory Research
Other
Based on regional and country-level analysis, the Isothermal Nucleic Acid Amplification Technology (INAAT) market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Isothermal Nucleic Acid Amplification Technology (INAAT) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Grifols
Hologic
Abbott Laboratories
BD
Meridian Bioscience
Eiken Chemical
Quidel Corporation
QIAGEN
bioMerieux
Tecan
DiaSorin
Thermo Fisher Scientific
Illumina
New England Biolabs
TwistDx
Mast Group
Lucigen Corporation
Ustar Biotechnologies
Genomtec
Jena Bioscience
OptiGene
Sysmex Corporation
Premier Biosoft
mFluiDx
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth Rate by Type: 2020 VS 2026
- 1.2.2 Loop-mediated Isothermal Amplification
- 1.2.3 Nucleic Acid Sequence-based Amplification
- 1.2.4 Rolling Circle Amplification
- 1.2.5 Single Primer Isothermal Amplification
- 1.2.6 Helicase-dependent Isothermal DNA Amplification
- 1.2.7 Recombinase Polymerase Amplification
- 1.2.8 Strand Displacement Amplification
- 1.3 Market by Application
- 1.3.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Application: 2020 VS 2026
- 1.3.2 Infectious Disease Diagnosis
- 1.3.3 Blood Screening
- 1.3.4 Cancer Diagnosis
- 1.3.5 Cancer Research and Laboratory Research
- 1.3.6 Other
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Perspective (2015-2026)
- 2.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Growth Trends by Regions
- 2.2.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Share by Regions (2015-2020)
- 2.2.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Isothermal Nucleic Acid Amplification Technology (INAAT) Players by Market Size
- 3.1.1 Global Top Isothermal Nucleic Acid Amplification Technology (INAAT) Players by Revenue (2015-2020)
- 3.1.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Players (2015-2020)
- 3.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue
- 3.4 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Concentration Ratio
- 3.4.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue in 2019
- 3.5 Key Players Isothermal Nucleic Acid Amplification Technology (INAAT) Area Served
- 3.6 Key Players Isothermal Nucleic Acid Amplification Technology (INAAT) Product Solution and Service
- 3.7 Date of Enter into Isothermal Nucleic Acid Amplification Technology (INAAT) Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Isothermal Nucleic Acid Amplification Technology (INAAT) Breakdown Data by Type (2015-2026)
- 4.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Size by Type (2015-2020)
- 4.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Type (2021-2026)
5 Isothermal Nucleic Acid Amplification Technology (INAAT) Breakdown Data by Application (2015-2026)
- 5.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Size by Application (2015-2020)
- 5.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2015-2026)
- 6.2 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2015-2020)
- 6.3 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2015-2020)
- 6.4 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2015-2026)
- 7.2 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2015-2020)
- 7.3 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2015-2020)
- 7.4 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
- 7.4.7 Rest of Europe
8 China
- 8.1 China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2015-2026)
- 8.2 China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2015-2020)
- 8.3 China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2015-2020)
- 8.4 China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
- 8.4.7 Rest of Asia-Pacific
9 Japan
- 9.1 Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2015-2026)
- 9.2 Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2015-2020)
- 9.3 Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2015-2020)
- 9.4 Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Southeast Asia
- 10.1 Southeast Asia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2015-2026)
- 10.2 Southeast Asia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2015-2020)
- 10.3 Southeast Asia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2015-2020)
- 10.4 Southeast Asia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
- 10.4.4 Rest of Middle East & Africa
11Key Players Profiles
- 11.1 Grifols
- 11.1.1 Grifols Company Details
- 11.1.2 Grifols Business Overview
- 11.1.3 Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 11.1.4 Grifols Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020))
- 11.1.5 Grifols Recent Development
- 11.2 Hologic
- 11.2.1 Hologic Company Details
- 11.2.2 Hologic Business Overview
- 11.2.3 Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 11.2.4 Hologic Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 11.2.5 Hologic Recent Development
- 11.3 Abbott Laboratories
- 11.3.1 Abbott Laboratories Company Details
- 11.3.2 Abbott Laboratories Business Overview
- 11.3.3 Abbott Laboratories Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 11.3.4 Abbott Laboratories Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 11.3.5 Abbott Laboratories Recent Development
- 11.4 BD
- 11.4.1 BD Company Details
- 11.4.2 BD Business Overview
- 11.4.3 BD Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 11.4.4 BD Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 11.4.5 BD Recent Development
- 11.5 Meridian Bioscience
- 11.5.1 Meridian Bioscience Company Details
- 11.5.2 Meridian Bioscience Business Overview
- 11.5.3 Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 11.5.4 Meridian Bioscience Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 11.5.5 Meridian Bioscience Recent Development
- 11.6 Eiken Chemical
- 11.6.1 Eiken Chemical Company Details
- 11.6.2 Eiken Chemical Business Overview
- 11.6.3 Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 11.6.4 Eiken Chemical Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 11.6.5 Eiken Chemical Recent Development
- 11.7 Quidel Corporation
- 11.7.1 Quidel Corporation Company Details
- 11.7.2 Quidel Corporation Business Overview
- 11.7.3 Quidel Corporation Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 11.7.4 Quidel Corporation Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 11.7.5 Quidel Corporation Recent Development
- 11.8 QIAGEN
- 11.8.1 QIAGEN Company Details
- 11.8.2 QIAGEN Business Overview
- 11.8.3 QIAGEN Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 11.8.4 QIAGEN Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 11.8.5 QIAGEN Recent Development
- 11.9 bioMerieux
- 11.9.1 bioMerieux Company Details
- 11.9.2 bioMerieux Business Overview
- 11.9.3 bioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 11.9.4 bioMerieux Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 11.9.5 bioMerieux Recent Development
- 11.10 Tecan
- 11.10.1 Tecan Company Details
- 11.10.2 Tecan Business Overview
- 11.10.3 Tecan Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 11.10.4 Tecan Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 11.10.5 Tecan Recent Development
- 11.11 DiaSorin
- 10.11.1 DiaSorin Company Details
- 10.11.2 DiaSorin Business Overview
- 10.11.3 DiaSorin Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 10.11.4 DiaSorin Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 10.11.5 DiaSorin Recent Development
- 11.12 Thermo Fisher Scientific
- 10.12.1 Thermo Fisher Scientific Company Details
- 10.12.2 Thermo Fisher Scientific Business Overview
- 10.12.3 Thermo Fisher Scientific Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 10.12.4 Thermo Fisher Scientific Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 10.12.5 Thermo Fisher Scientific Recent Development
- 11.13 Illumina
- 10.13.1 Illumina Company Details
- 10.13.2 Illumina Business Overview
- 10.13.3 Illumina Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 10.13.4 Illumina Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 10.13.5 Illumina Recent Development
- 11.14 New England Biolabs
- 10.14.1 New England Biolabs Company Details
- 10.14.2 New England Biolabs Business Overview
- 10.14.3 New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 10.14.4 New England Biolabs Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 10.14.5 New England Biolabs Recent Development
- 11.15 TwistDx
- 10.15.1 TwistDx Company Details
- 10.15.2 TwistDx Business Overview
- 10.15.3 TwistDx Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 10.15.4 TwistDx Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 10.15.5 TwistDx Recent Development
- 11.16 Mast Group
- 10.16.1 Mast Group Company Details
- 10.16.2 Mast Group Business Overview
- 10.16.3 Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 10.16.4 Mast Group Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 10.16.5 Mast Group Recent Development
- 11.17 Lucigen Corporation
- 10.17.1 Lucigen Corporation Company Details
- 10.17.2 Lucigen Corporation Business Overview
- 10.17.3 Lucigen Corporation Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 10.17.4 Lucigen Corporation Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 10.17.5 Lucigen Corporation Recent Development
- 11.18 Ustar Biotechnologies
- 10.18.1 Ustar Biotechnologies Company Details
- 10.18.2 Ustar Biotechnologies Business Overview
- 10.18.3 Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 10.18.4 Ustar Biotechnologies Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 10.18.5 Ustar Biotechnologies Recent Development
- 11.19 Genomtec
- 10.19.1 Genomtec Company Details
- 10.19.2 Genomtec Business Overview
- 10.19.3 Genomtec Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 10.19.4 Genomtec Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 10.19.5 Genomtec Recent Development
- 11.20 Jena Bioscience
- 10.20.1 Jena Bioscience Company Details
- 10.20.2 Jena Bioscience Business Overview
- 10.20.3 Jena Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 10.20.4 Jena Bioscience Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 10.20.5 Jena Bioscience Recent Development
- 11.21 OptiGene
- 10.21.1 OptiGene Company Details
- 10.21.2 OptiGene Business Overview
- 10.21.3 OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 10.21.4 OptiGene Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 10.21.5 OptiGene Recent Development
- 11.22 Sysmex Corporation
- 10.22.1 Sysmex Corporation Company Details
- 10.22.2 Sysmex Corporation Business Overview
- 10.22.3 Sysmex Corporation Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 10.22.4 Sysmex Corporation Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 10.22.5 Sysmex Corporation Recent Development
- 11.23 Premier Biosoft
- 10.23.1 Premier Biosoft Company Details
- 10.23.2 Premier Biosoft Business Overview
- 10.23.3 Premier Biosoft Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 10.23.4 Premier Biosoft Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 10.23.5 Premier Biosoft Recent Development
- 11.24 mFluiDx
- 10.24.1 mFluiDx Company Details
- 10.24.2 mFluiDx Business Overview
- 10.24.3 mFluiDx Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 10.24.4 mFluiDx Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 10.24.5 mFluiDx Recent Development
- 11.25 Cangene
- 10.25.1 Cangene Company Details
- 10.25.2 Cangene Business Overview
- 10.25.3 Cangene Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
- 10.25.4 Cangene Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2015-2020)
- 10.25.5 Cangene Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Summary:
Get latest Market Research Reports on Isothermal Nucleic Acid Amplification Technology (INAAT) . Industry analysis & Market Report on Isothermal Nucleic Acid Amplification Technology (INAAT) is a syndicated market report, published as Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Isothermal Nucleic Acid Amplification Technology (INAAT) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
